يعرض 21 - 30 نتائج من 111 نتيجة بحث عن '"Vazquez-Estevez, Sergio"', وقت الاستعلام: 1.36s تنقيح النتائج
  1. 21
    مؤتمر
    Prevalence of cancer-related pain in different tumor entities: ATLAS Study in Spanish oncology units

    الإتاحة: https://doi.org/20.500.11940/8219Test
    https://hdl.handle.net/20.500.11940/8219Test

    View record in BASE

    أضف إلى المفضلة
  2. 22
    مؤتمر
    Phase II study of pazopanib and weekly paclitaxel in metastatic or locally advanced squamous penile carcinoma patients previously treated with cisplatin-based chemotherapy: PAZOPEN study

    الإتاحة: https://doi.org/20.500.11940/6039Test
    https://hdl.handle.net/20.500.11940/6039Test

    View record in BASE

    أضف إلى المفضلة
  3. 23
    مؤتمر
    JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study

    الإتاحة: https://doi.org/20.500.11940/6028Test
    https://hdl.handle.net/20.500.11940/6028Test

    View record in BASE

    أضف إلى المفضلة
  4. 24
    مؤتمر
    Safety of cabazitaxel (Cbz) in patients (pt) with metastatic transitional-cell carcinoma (mTCC) progressing to cisplatin-based chemotherapy: Results from the JEVTCC-SOGUG Study

    الإتاحة: https://doi.org/20.500.11940/6041Test
    https://hdl.handle.net/20.500.11940/6041Test

    View record in BASE

    أضف إلى المفضلة
  5. 25
    مؤتمر
    Prospective validation of prognostic classifications in patients (pt) progressing to first-line chemotherapy in metastatic transitional-cell carcinoma (mTCC)

    الإتاحة: https://doi.org/20.500.11940/6019Test
    https://hdl.handle.net/20.500.11940/6019Test

    View record in BASE

    أضف إلى المفضلة
  6. 26
    مؤتمر
    Quality of life assessment in patients with advanced renal cancer: CAVIREN study

    الإتاحة: https://doi.org/20.500.11940/6027Test
    https://hdl.handle.net/20.500.11940/6027Test

    View record in BASE

    أضف إلى المفضلة
  7. 27
    مؤتمر
    Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the international metastatic renal-cell carcinoma database consortium prognostic model (IMRCC). The SPAZO study (SOGUG)

    الإتاحة: https://doi.org/20.500.11940/6020Test
    https://hdl.handle.net/20.500.11940/6020Test

    View record in BASE

    أضف إلى المفضلة
  8. 28
    مؤتمر
    Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

    الإتاحة: https://doi.org/20.500.11940/1926Test
    https://hdl.handle.net/20.500.11940/1926Test

    View record in BASE

    أضف إلى المفضلة
  9. 29
    مؤتمر
    Long-Term Survivors with EGFR Wild-Type Advanced NSCLC Treated with Second-Line Erlotinib: Subgroup Analysis from WILT Study

    الإتاحة: https://doi.org/20.500.11940/988Test
    https://hdl.handle.net/20.500.11940/988Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  10. 30
    مؤتمر
    Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)

    الإتاحة: https://doi.org/20.500.11940/746Test
    https://hdl.handle.net/20.500.11940/746Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث